TOFUTTI BRANDS INC
For the period ended Mar 29, 2025. Filed May 19, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 29, 2025 · Filed May 19, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Unaudited Condensed Financial Statements
Note 1: Basis of Presentation
The accompanying unaudited condensed financial information, in the opinion of management, reflects all adjustments (which include only normally recurring adjustments) necessary to present fairly the Company’s financial position, operating results and cash flows for the periods presented. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission. The results of operations for the thirteen-week period ended March 29, 2025 are not necessarily indicative of the results to be expected for the full year or any other period.
The Company’s fiscal year is either a fifty-two or fifty-three-week period which ends on the Saturday closest to December 31 st.
Note 2: Recently Issued Accounting Standards
The Company considers the applicability and impact of all Accounting Standard Updates (“ASUs”). ASUs not discussed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company’s balance sheets or statements of operations.
In November 2023, the FASB issued ASU 2023-07,Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The standard is effective for annual reporting periods beginning after December 15, 2023, and interim periods beginning after December 15, 2024. The Company’s adoption of this standard effective for the fiscal year ending December 28, 2024 resulted in increased disclosures in the notes to its financial statements.
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”), and in January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date (“ASU 2025-01”). ASU 2024-03 requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. ASU 2024-03, as clarified by ASU 2025-01, is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of these standards will have on it financial statements.
In December 2023, the FASB issued ASU 2023-09,Income Taxes (Topic 740) – Improvements to Income Tax Disclosures (ASU 2023-09). ASU 2023-09 requires that an entity, on an annual basis, disclose additional income tax information, primarily related to the rate reconciliation and income taxes paid. The amendment in the ASU is intended to enhance the transparency and decision usefulness of income tax disclosures. The ASU’s amendments are effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the impact that adoption of ASU 2023-09 will have on its financial statements.
Note 3: Inventories
Inventories consist of the following:
| March 29, 2025 | December 28, 2024 | |
|---|---|---|
| Finished products | $1,200 | $1,101 |
| Raw materials and packaging | 944 | 778 |
| Inventories, net | $2,144 | $1,879 |
Note 4: Income Taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company accounts for penalties or interest related to uncertain tax positions as part of its provision for income taxes.
The Company recognized income tax expense of $0 for the thirteen-week periods ended March 29, 2025 and March 30, 2024. The Company recorded a full valuation allowance on the deferred tax asset as of March 29, 2025.
Note 5: Earnings (Loss) Per Share
Basic earnings per common share (“EPS”) applicable to common stockholders is computed by dividing earnings applicable to common stockholders by the weighted-average number of common shares outstanding. If there is a loss from operations, diluted EPS is computed in the same manner as basic EPS is computed.
The following table sets forth the computation of basic and diluted earnings per share:
| Thirteen weeks ended March 29, 2025 | Thirteen weeks ended March 30, 2024 | |
|---|---|---|
| Net Loss, numerator, basic computation | $(162) | $(303) |
| Net Loss, numerator, diluted computation | (162) | (303) |
| Weighted average shares - denominator basic computation | 5,154 | 5,154 |
| Weighted average shares, as adjusted - denominator diluted computation | 5,154 | 5,154 |
| Net Loss per common share - basic | $(0.03) | $(0.06) |
| Net Loss per common share - diluted | $(0.03) | $(0.06) |
The following are securities excluded from weighted-average shares used to calculate diluted Net loss per common share, as the result of including them to calculate diluted EPS is anti-dilutive:
| Thirteen weeks Ended March 29, 2025 | Thirteen weeks Ended March 30, 2024 | |
|---|---|---|
| Shares subject to outstanding common stock options | 250,000 | 250,000 |
Note 6: Share Based Compensation
On June 10, 2014, the shareholders of the Company approved the 2014 Equity Incentive Plan (the “2014 Plan”). The 2014 Plan provides for grants of various types of awards that are designed to attract and retain highly qualified personnel who will contribute to the success of the Company and to provide incentives to participants in the 2014 Plan that are linked directly to increases in shareholder value which will therefore ensure to the benefit of all shareholders of the Company. Such grants can be, but are not limited to, options, stock appreciation rights, restricted stock, performance grants, stock bonuses, and any other type of award that is consistent with the purposes of the 2014 Plan. Employees and officers of the Company are eligible to receive incentive stock options while corporate directors are only eligible to receive non-qualified options.
The 2014 Plan made 250,000 shares of common stock available for awards. The 2014 Plan also permits performance-based 2014 awards paid under it to be tax deductible under Section 162(m) of the Internal Revenue Code of 1986, as amended, as “performance-based compensation.”No stock options have been granted since 2022. In 2022,250,000 stock options were issued, and as of March 29, 2025,250,000 non-qualified stock options remain outstanding. The exercise price of all options granted in 2022 is $0.95 per share, the market price at the close of business on the date of the grant.83,333 of the options vested at the respective grant date,83,333 vested in December 2023, and 83,334 vested in December 2024. All options expire on December 22, 2027.
The following is a summary of stock option activity from December 28, 2024 to March 29, 2025:
| NON-QUALIFIED OPTIONS | ||
|---|---|---|
| Shares | Weighted Average Exercise Price ($) | |
| Outstanding at December 28, 2024 | 250,000 | 0.95 |
| Granted | — | — |
| Exercised | — | — |
| Outstanding at March 29, 2025 | 250,000 | 0.95 |
| Exercisable at March 29, 2025 | 250,000 | 0.95 |
The following table summarizes information about stock options outstanding from December 29, 2024 to March 29, 2025:
| Range of Exercise Prices ($) | Number Outstanding | Weighted Average Remaining Life (in years) | Weighted Average Exercise Price($) | Number Exercisable |
|---|---|---|---|---|
| $0.95 | 250,000 | 1.75 | $0.95 | 250,000 |
As of March 29, 2025 and March 30, 2024 the intrinsic value of the options outstanding and exercisable options was $0. As of March 29, 2025 there was $0 of total unrecognized compensation cost. Total stock-based compensation for the thirteen weeks ended March 29, 2025 and March 30, 2024 was $0 and $14, respectively, which is recorded in general and administrative expenses on the statement of operations.
Note 7: Revenue
Performance obligations relating to the delivery of food products are satisfied when the goods are shipped to the customer and net of all applicable discounts, as follows: Payment term discounts, off-invoice allowance, manufacturer chargeback, freight allowance, spoilage discounts, and product returns.
Revenues by geographical region are as follows:
| Thirteen weeks ended March 29, 2025 | Thirteen weeks ended March 30, 2024 | |
|---|---|---|
| Revenues by geography: | ||
| Americas | $1,499 | $2,125 |
| Middle East | 92 | 87 |
| Total Net Sales | $1,591 | $2,212 |
Approximately 94% of the Americas’ revenue for the thirteen weeks ended March 29, 2025 is attributable to sales in the United States compared with 90% of the Americas’ revenue for the thirteen weeks ended March 30, 2024. All of the Company’s assets are located in the United States.
Net sales by major product category:
| Thirteen weeks ended March 29, 2025 | Thirteen weeks ended March 30, 2024 | |
|---|---|---|
| Frozen desserts and foods | $218 | $403 |
| Cheeses | 1,373 | 1,809 |
| Total Net Sales | $1,591 | $2,212 |
Note 8: Leases
In 2024, the Company signed a five-year lease to move our offices into a one-story facility in Edison, New Jersey. The 5,100 square foot facility houses our administrative offices, a warehouse, freezers, and refrigerators .The lease commenced on July 1 2024, with an option to extend for an additional five years at the end of the lease. Annual rent for the lease escalates by 3% year over year until the end of the lease term. We completed the move into the new facility in September 2024. The Company determined that this lease met the criteria for classification as an operating lease under ASC 842. Rent expense was $21 and $27 for the thirteen weeks ended March 29, 2025 and March 30, 2024. The Company also rents warehouse storage space at various outside facilities. Outside warehouse expenses were $77 for the thirteen weeks ended March 29, 2025 and $82 for the thirteen weeks ended March 30, 2024. The Company has determined that these warehouse leases do not fall within the scope of ASC 842, as they are either month-to-month leases or have terms of 12 months or less. The Company rents a copier and mail machine under a finance lease. In 2022, the Company entered into a copier and mail machine lease, which still exists as of March 29, 2025. Payments for the copier and mail machine amounted to $2 for the thirteen weeks ended March 29, 2025 and $4 for the thirteen weeks ended March 30, 2024.
Under Topic 842, operating lease expense is generally recognized evenly over the term of the lease. The standard requires a lessee to record a right-of-use asset and a corresponding lease liability at the inception of the lease. The current portion of lease liabilities is included in accrued expenses on the condensed balance sheets.
Under Topic 842, finance lease cost includes amortization, which is recognized on a straight-line basis over the expected life of the leased asset, and interest expense, which is recognized following an effective interest rate method. The Company has a finance lease consisting of a copier lease with a term of four years. The standard requires a lessee to record a right-of-use asset and a corresponding lease liability at the inception of the lease.
The Company’s lease agreements generally do not provide an implicit borrowing rate; therefore, an internal incremental borrowing rate is determined based on information available at lease commencement date for purposes of determining the present value of lease payments. The Company used the incremental borrowing rates of between 5.5% and 6.5% for all leases.
ROU lease assets and lease liabilities for our operating leases were recorded in the balance sheet as follows:
| As of | As of | |
|---|---|---|
| March 29, 2025 | December 28, 2024 | |
| Operating lease right-of-use assets | $323 | $340 |
| Current portion of lease liabilities | 65 | 64 |
| Operating lease liabilities, net of current portion | 274 | 283 |
| Total lease liability | $339 | $347 |
| Weighted average remaining lease term (in years) | 4.4 | 4.7 |
| Weighted average discount rate | 5.5% | 5.5% |
ROU lease asset and lease liability for our finance lease were recorded in the balance sheet as follows:
| As of | As of | |
|---|---|---|
| March 29, 2025 | December 28, 2024 | |
| Finance lease right-of-use asset | $17 | $21 |
| Current portion of lease liabilities | 17 | 16 |
| Finance lease liabilities, net of current portion | 1 | 6 |
| Total finance lease liabilities | $18 | $22 |
| Weighted average remaining lease term (in years) | 1.17 | 1.4 |
| Weighted average discount rate | 6.5% | 6.5% |
Future lease payments included in the measurement of lease liabilities on the balance sheet as of March 29, 2025 are as follows:
| Operating lease liabilities · Finance lease liability · Total | |||
|---|---|---|---|
| 2025 (remainder of the year) | $61 | $13 | $74 |
| 2026 | 84 | 7 | 91 |
| 2027 | 86 | — | 86 |
| 2028 | 89 | — | 89 |
| 2029 | 53 | — | 53 |
| Total future minimum lease payments | 373 | 20 | 393 |
| Present value adjustment | (34) | (2) | (36) |
| Total | $339 | $18 | $357 |
Note 9: Commitments and Contingencies
The Company sells its products throughout the United States and in approximately twelve foreign countries and may be impacted by any future public health crises beyond its control. This could disrupt its operations and negatively impact sales of its products. The Company’s customers, suppliers and co-packers may experience similar disruption.. Our selling prices may be affected due to market changes, increased competition, the general risk of inflation, the impacts of tariffs or the responses of other governments, consumers or suppliers to U.S. imposed tariffs, shortages or interruptions in supply due to weather, disease or other conditions beyond our control, or other reasons. While there are no current tariffs that have affected any of the Company’s imports or exports, uncertainty regarding their implementation has already influenced the purchasing decisions of some of our domestic and international customers.
Note 10: Accrued Expenses
Accrued expenses and other current liabilities consist of the following:
| As of · As of | |||
|---|---|---|---|
| March 29, 2025 · December 28, 2024 | |||
| Accrued payroll and other benefits | $1 | $ | - |
| Accrued professional fees | 15 | - | |
| Uncertain tax position | 211 | 211 | |
| Current portion of operating lease liability | 65 | 64 | |
| Total accrued expenses | $292 | $275 | |
Note 11: Related Party Transactions
During the thirteen weeks ending March 29, 2025 and March 30, 2024, we paid The CFO Squad $2,000 and $1,000, respectively, for financial services. Joseph Himy is the Managing Director of The CFO Squad and a member of our Board of Directors. No amounts were accrued in our balance sheet for services provided by CFO Squad during the thirteen weeks ended March 29, 2025, and March 30, 2024.
Note 12: Segment Information
The Company views its operations and manages its business in one reportable segment, which is the development, production and marketing of soy and other vegetable protein- based, dairy free cheese and frozen food products.
Steven Kass, the Company’s Chief Executive Officer and Chief Financial Officer is the Chief Operating Decision Maker (“CODM”). The CODM evaluates performance and makes operating decisions about allocating resources based on net loss and cash balances presented in the accompanying statement of operations and balance sheet, respectively.
The measure of segment assets is reported on the balance sheets as total assets. Any long-lived assets are located in the United States.
NOTE 13: Customer Concentrations
As of March 29, 2025 three customers accounted for 12%,19%, and 12% of accounts receivable, respectively. There was one customer that accounted for 10% of accounts receivable as of March 30, 2024.
For sales, one customer represented 16% and another customer accounted for 24% of total sales, for the thirteen weeks ended March 29, 2025. For the thirteen weeks ended March 30, 2024 three customers accounted for 15%,20%, and 11% of sales, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.